SCHEDULE OF STOCKHOLDERS' EQUITY NOTE, WARRANTS OR RIGHTS (Details) |
Jun. 30, 2022
$ / shares
shares
|
|---|---|
| Warrants Issued in Connection with Issuance of Series B Preferred Stock to Lead Investor [Member] | |
| Class of Stock [Line Items] | |
| Number of warrants | shares | 11,875 |
| Exercise price per share | $ / shares | $ 10.00 |
| Average remaining term in years | 6 months 14 days |
| Warrants issued in connection with convertible notes [Member] | |
| Class of Stock [Line Items] | |
| Number of warrants | shares | 25,208 |
| Exercise price per share | $ / shares | $ 24.00 |
| Average remaining term in years | 4 months 2 days |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|